お知らせ • Apr 07
ReGen III Corp., Annual General Meeting, May 29, 2026 ReGen III Corp., Annual General Meeting, May 29, 2026. Location: british columbia, vancouver Canada お知らせ • Apr 03
ReGen III Corp. announced that it has received CAD 4.037572 million in funding from Embley Park Foundation and other investors On April 1, 2026, ReGen III Corp. closed the oversubscribed transaction. The company issued 3,000,000 units at an issue price of CAD 0.20 for gross proceeds of CAD 600,000 in its third and final tranche. The transaction includes participation from, Brad Kotush for 125,000 units for gross proceeds of CAD 25,000, Embley Park Foundation for 1,125,000 units for gross proceeds of CAD 225,000 and Liam Gallacher for 1,625,000 units for gross proceeds of CAD 325,000. Over the course of closing the three tranches of the offering, the company has issued 20,187,860 units for aggregate gross proceeds of CAD 4,037,572. All securities issued in the final tranche will be subject to a statutory four-month hold period ending August 2, 2026. The company paid finders' fees of CAD 5,000 in cash for final tranche. The company paid total CAD 80,750 as finder's fees related to the offering. The closing of the offering is subject to receipt of al necessary regulatory approvals, including final approval by the TSX Venture Exchange. Insiders of the company purchased 2,875,000 units, representing 14.24% of aggregate units issued in the offering, with the associated common shares representing approximately 1.86% of the issued and outstanding common shares following the closing of the final tranche. The private placement was approved by the board of directors of the company. お知らせ • Mar 05
ReGen III Corp. announced that it expects to receive CAD 4 million in funding ReGen III Corp. announces a non-brokered private placement to issue 20,000,000 units of the company at a price of CAD 0.20 per unit for gross proceeds of CAD 4,000,000 on March 4, 2026. Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant. Each warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.30 per warrant share for a period of three years from the date of issuance. The closing of the offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange. In connection with the offering, the company may pay certain finders' fees subject to compliance with applicable securities laws and the rules of the exchange. The securities issued pursuant to the offering will be subject to a statutory four-month hold period. お知らせ • May 27
ReGen III Corp. announced that it expects to receive CAD 2 million in funding ReGen III Corp announced a non brokered private placement to issue 10,000,000 Units at a price of CAD 0.2 per unit for aggregate gross proceeds of CAD 2,000,000. Each Unit will consist of One common share and one-half of one common share purchase warrant. Each Warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.45 per Warrant for a period of two years from the date of issuance. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange. お知らせ • Nov 25
ReGen III Corp. announced that it has received CAD 0.89 million in funding On November 25, 2024, ReGen III Corp. closed the transaction. The company issued 1,800,000 Units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 360,000 in its final tranche. On an aggregate basis, across the initial and Final Tranche of the non-brokered private placement, the Company issued 4,450,000 Units for gross proceeds of CAD 890,000. All securities issued in the Final Tranche are subject to a hold period expiring on March 23, 2025. In connection with the Final Tranche, the Company paid aggregate finders' fees of CAD 7,000 in cash. The Offering is subject to the final approval of the Exchange. お知らせ • Oct 22
ReGen III Corp., Annual General Meeting, Dec 19, 2024 ReGen III Corp., Annual General Meeting, Dec 19, 2024. Location: british columbia, vancouver Canada お知らせ • Oct 08
ReGen III Corp. announced that it expects to receive CAD 0.5 million in funding ReGen III Corp. announced a non-brokered private placement of up to 2,500,000 units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 500,000 on October 7, 2024. Each unit will consist of one common share and one common share purchase warrant entitling the holder to purchase a further common share at a price of CAD 0.30 for a period of 36 months after the closing. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the Exchange. お知らせ • Sep 24
ReGen III Corp. Announces CEO Changes ReGen III Corp. announced that effective immediately Greg Clarkes, CEO and Chairman of the Board, has stepped down from his role as CEO for personal reasons. Mr. Clarkes will continue to serve as Chairman of the Board, providing ongoing leadership and guidance to the Company. Mr. Clarkes founded ReGen III in 2017, securing the underlying process patent suite and re-capitalizing the firm's strategic shift to high-value re-refining. Amongst other corporate milestones, Mr. Clarkes was integral to securing FEL2 financing and negotiating the Company's multi-year offtake agreement with bp Products North America. Mr. Clarkes was also a strong supporter of building out the Company's intellectual property, wherein the Company has validated, de-risked and protected its proprietary ReGen process through numerous technical studies and 32 pending or awarded patents. Effective immediately, Mark Redcliffe, President of ReGen III, will assume the roles of CEO and President. お知らせ • Jul 16
ReGen III Corp. announced that it has received CAD 1.075 million in funding On July 15, 2024, ReGen III Corp. closed the transaction. The company has issued 300 Convertible Debenture Units at a price of CAD 1,000 per unit for aggregate gross proceeds of CAD 300,000 in its second and final tranche closing. The company has now issued total 1,075 Convertible Debenture Units at a price of CAD 1,000 per unit for total gross proceeds of CAD 1,075,000 in the transaction. The Debentures and Warrants issued in this final tranche and any underlying common shares are subject to a hold period expiring on November 16, 2024. A director of the company acquired ownership or control over an additional 100 units in the final tranche, the underlying debenture and warrants which if immediately converted and exercised respectively as of closing would result in the issue of 281,818 common shares representing approximately 0.238% of the then issued and outstanding common shares. お知らせ • Apr 30
ReGen III Corp. announced that it expects to receive CAD 2 million in funding ReGen III Corp. announced a non-brokered private placement of up to 2,000 convertible debenture units at a price of CAD 1,000 per unit for gross proceeds of up to CAD 2,000,000 on April 30, 2024. Each unit will consist of a CAD 1,000 in principal amount of unsecured convertible debenture and 1,000 common share purchase warrants of the company. Each warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing. The debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the company may elect to pay outstanding interest in common shares at a price per share equal to the volume-weighted average price of the common shares on the TSX Venture Exchange for the five trading days prior to the date such interest is due. The debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share. After four months, the company may redeem the debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or interest shares or a combination thereof. Finder fees may be paid in accordance with the policies of the exchange, subject to compliance with applicable law and exchange approval. The placement may be closed in one or more tranches. The debentures, the warrants and any underlying common shares will be subject to a four-month hold period from closing. The certificates representing the debentures and the warrants will contain such additional terms and conditions as are considered necessary or advisable by the company. The placement, including but not limited to the payment of any finder fees and any future issuance of interest shares, remains subject to exchange approval. お知らせ • Oct 31
ReGen III Corp. announced that it expects to receive CAD 5 million in funding ReGen III Corp announces private placement of 5,000 Convertible Debenture Units at a price of CAD 1,000 per Unit for gross proceeds of CAD 5,000,000 on October 30, 2023.Each Unit will consist of a $1,000 in principal amount of unsecured convertible debenture (a "Debenture") and 1,000 common share purchase warrants of the Company (a "Warrant"). Each Warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing.The Debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the Company may elect to pay outstanding interest in common shares ("Interest Shares") at a price per share equal to the volume weighted average price of the common shares on the TSX Venture Exchange (the "Exchange") for the 5 trading days prior to the date such interest is due. The Debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share.After 4 months, the Company may redeem the Debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or Interest Shares or a combination thereof. The Placement may be closed in one or more tranches. The Debentures, the Warrants and any underlying common shares will be subject to a four month hold period from closing. お知らせ • Oct 21
ReGen III Corp., Annual General Meeting, Dec 21, 2023 ReGen III Corp., Annual General Meeting, Dec 21, 2023. Location: Vancouver, BC Vancouver Canada お知らせ • Jun 23
ReGen III Corp. Appoints Rick Low as Chief Financial Officer ReGen III Corp. announced the appointment of Rick Low as Chief Financial Officer, effective immediately. Mr. Low, most recently the company's Manager, Finance & Accounting, will now assume the responsibilities previously held by Steve Martin. With over 25 years of progressive management experience in various industries, both in Canada and overseas, Mr. Low brings a wealth of expertise to his new role. He possesses a remarkable track record of more than 15 years in senior management, including extensive experience as the Company's original Chief Financial Officer from September 2012 to October 2021. Mr. Low has successfully overseen the finance and accounting functions of a pre-revenue company, leading it through the critical stages of feasibility, construction, development and ultimately, commercial production and revenue generation. Throughout his career, Mr. Low has been instrumental in raising significant debt and equity financings, as well as facilitating applications for listing on stock exchanges. His comprehensive understanding of financial operations, combined with his strategic vision, will greatly contribute to helping ReGen III achieve its corporate milestones and growth plans.